Updates

Chemring

July 2006

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Chemring has announced the sale of its non-core marine lights business, which manufactures marine lights for lifejackets and liferafts, for £2.85m. The price was just shy of its gross asset value of £3m. The shares have been weak ever since the May shake-out and although there’s been no reason for it as of yet, we would suggest setting a stop-loss of 866p as a precaution. ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Gulfsands

Synergy Healthcare

Chemring - Defence firm expects growth from “reverse peace dividend” (August 2022)

Chemring - Defence specialist winning big contracts with USâ€ˆmilitary (December 2019)

Chemring - Forward PE less than 6 but outlook increasingly uncertain (January 2012)

Chemring - Defence business finding new sources of growth (December 2011)

Chemring - Aquisitions driving share price higher (February 2010)

Chemring - Wins huge contract (November 2009)

Chemring - Defence firm exploiting activity in Iraq and Afghanistan (September 2009)

Chemring (November 2008)

Chemring - Eps of 193p forecast for 2009 (August 2008)

Chemring - Order book rises to a record £420m (May 2008)

Chemring - Defence firm set to increase eps 71% over next two years (March 2008)

Chemring - Order book up 50% (January 2008)

Chemring (June 2007)

Chemring - Shares break over Â£20 (May 2007)

Chemring - Eps forecasts raised 10% to 101p (March 2007)

Chemring - Take part profit (January 2007)

Chemring - Order book hits another record (November 2006)

Chemring (August 2006)

Chemring - Positive AGM (May 2006)

Chemring - Benefiting from massive US defence contract wins (April 2006)

Chemring - Supplier of countermeasures growing on back of US military spend (February 2006)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

Chemring

July 2006

Related Articles